DENTSPLY SIRONA (NASDAQ:XRAY) Receives “Outperform” Rating from Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “outperform” rating reissued by Barrington Research in a research report issued on Friday, Benzinga reports. They currently have a $36.00 price target on the medical instruments supplier’s stock. Barrington Research’s price objective points to a potential upside of 36.93% from the stock’s previous close.

XRAY has been the topic of several other research reports. Stifel Nicolaus cut their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Evercore ISI cut their target price on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, August 20th. Finally, Robert W. Baird cut their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Moderate Buy” and a consensus price target of $33.22.

DENTSPLY SIRONA Trading Down 2.3 %

NASDAQ XRAY opened at $26.29 on Friday. The company has a market cap of $5.46 billion, a price-to-earnings ratio of -59.75, a P/E/G ratio of 1.25 and a beta of 1.00. DENTSPLY SIRONA has a 52 week low of $23.58 and a 52 week high of $37.60. The business has a 50 day moving average price of $25.56 and a 200-day moving average price of $27.86. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.51 EPS. As a group, equities analysts expect that DENTSPLY SIRONA will post 1.99 earnings per share for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in DENTSPLY SIRONA by 44.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock worth $4,684,000 after acquiring an additional 43,230 shares during the last quarter. Seven Eight Capital LP bought a new position in DENTSPLY SIRONA in the 1st quarter worth about $1,409,000. Illinois Municipal Retirement Fund increased its stake in DENTSPLY SIRONA by 369.9% in the 1st quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock worth $4,102,000 after acquiring an additional 97,281 shares during the last quarter. Intech Investment Management LLC bought a new position in DENTSPLY SIRONA in the 1st quarter worth about $1,202,000. Finally, Duality Advisers LP bought a new position in DENTSPLY SIRONA in the 1st quarter worth about $1,166,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.